SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1 - General form for registration of securities under the Securities Act of 1933:
SEC Accession No. 0001654954-20-013481
Filing Date
2020-12-11
Accepted
2020-12-11 17:16:21
Documents
61

Document Format Files

Seq Description Document Type Size
1 FORM S-1 gtbp_s1.htm S-1 2251768
2 CONSENTS OF EXPERTS AND COUNSEL gtbp_ex23-1.htm EX-23.1 5043
3 IMAGE gtbp_ex23-1000.jpg GRAPHIC 13428
4 IMAGE gtbp_s1000.jpg GRAPHIC 2685
5 IMAGE gtbp_s1001.jpg GRAPHIC 29310
6 IMAGE gtbp_s1002.jpg GRAPHIC 6309
7 IMAGE gtbp_s1013.jpg GRAPHIC 5497
  Complete submission text file 0001654954-20-013481.txt   4768286

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT gtbp-20200930.xml EX-101.INS 483025
9 XBRL TAXONOMY EXTENSION SCHEMA gtbp-20200930.xsd EX-101.SCH 31328
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE gtbp-20200930_cal.xml EX-101.CAL 43271
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE gtbp-20200930_def.xml EX-101.DEF 61262
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE gtbp-20200930_lab.xml EX-101.LAB 195055
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gtbp-20200930_pre.xml EX-101.PRE 178369
Mailing Address 9350 WILSHIRE BLVD. SUITE 203 BEVERLY HILLS CA 90212
Business Address 9350 WILSHIRE BLVD. SUITE 203 BEVERLY HILLS CA 90212 (800) 304-9888
GT Biopharma, Inc. (Filer) CIK: 0000109657 (see all company filings)

IRS No.: 941620407 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1 | Act: 33 | File No.: 333-251311 | Film No.: 201384402
SIC: 2834 Pharmaceutical Preparations